Biotechnology Blueprint Medicines Provides 2023 Portfolio Goals to Achieve Precision at Scale January 5, 2023
Biotechnology Strength Seen in Fate Therapeutics (FATE): Can Its 9.3% Jump Turn into More Strength? January 5, 2023
Biotechnology Apellis Appoints Leading Retina Specialist Dr. Caroline Baumal as Chief Medical Officer January 5, 2023
Biotechnology BioMarin to Present at 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9, at 10:30 am PT /1:30 pm ET, in San Francisco, CA January 4, 2023
Search
biotech investments
